Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip W Connelly

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 12, 2008
Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathyPhilip W Connelly
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2016
Adiponectin, Adipokines, and the Need for Long-Term Human Studies With Comprehensive End PointsPhilip W Connelly, Anthony J Hanley
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 28, 2006
Unmasking of type III hyperlipoproteinemia by hypothyroidism: a dramatic illustration of altered lipoprotein metabolism in a postpartum womanRavi Retnakaran, Philip W Connelly, Jeannette Goguen
Critical Reviews in Clinical Laboratory Sciences|December 11, 2012
Adiponectin in renal disease--a review of the evidence as a risk factor for cardiovascular and all-cause mortalityPhilip W Connelly, G V Ramesh Prasad
Free Radical Biology & Medicine|December 21, 2004
Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitritePhilip W Connelly, Dragomir Draganov, Graham F Maguire
Journal of Lipid Research|January 3, 2004
Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activityPhilip W Connelly, Graham F Maguire, Dragomir I Draganov
Diabetes Care|November 25, 2003
Adiponectin in a native Canadian population experiencing rapid epidemiological transitionAnthony J G Hanley, Philip W Connelly, Stewart B Harris, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2015
The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA TrialCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
Diabetes, Obesity & Metabolism|February 10, 2017
Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetesCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
Cardiovascular Research|June 12, 2003
Formation of apolipoprotein AI-phosphatidylcholine core aldehyde Schiff base adducts promotes uptake by THP-1 macrophagesZakaria Ahmed, Amir Ravandi, Graham F Maguire, et al.
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 12, 2008
Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathyPhilip W Connelly
Arteriosclerosis, Thrombosis, and Vascular Biology|October 28, 2016
Adiponectin, Adipokines, and the Need for Long-Term Human Studies With Comprehensive End PointsPhilip W Connelly, Anthony J Hanley
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 28, 2006
Unmasking of type III hyperlipoproteinemia by hypothyroidism: a dramatic illustration of altered lipoprotein metabolism in a postpartum womanRavi Retnakaran, Philip W Connelly, Jeannette Goguen
Critical Reviews in Clinical Laboratory Sciences|December 11, 2012
Adiponectin in renal disease--a review of the evidence as a risk factor for cardiovascular and all-cause mortalityPhilip W Connelly, G V Ramesh Prasad
Free Radical Biology & Medicine|December 21, 2004
Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitritePhilip W Connelly, Dragomir Draganov, Graham F Maguire
Journal of Lipid Research|January 3, 2004
Separation and quantitative recovery of mouse serum arylesterase and carboxylesterase activityPhilip W Connelly, Graham F Maguire, Dragomir I Draganov
Diabetes Care|November 25, 2003
Adiponectin in a native Canadian population experiencing rapid epidemiological transitionAnthony J G Hanley, Philip W Connelly, Stewart B Harris, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2015
The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA TrialCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
Diabetes, Obesity & Metabolism|February 10, 2017
Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetesCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
Cardiovascular Research|June 12, 2003
Formation of apolipoprotein AI-phosphatidylcholine core aldehyde Schiff base adducts promotes uptake by THP-1 macrophagesZakaria Ahmed, Amir Ravandi, Graham F Maguire, et al.
Pageof 17